Tuesday, June 22, 2021

Pear Therapeutics to go public via SPAC mergerPear Therapeutics to go public via SPAC mergerPear Therapeutics to go public via SPAC merger

Pear Therapeutics to go public via SPAC merger

The deal values Pear Therapeutics, one of the first companies to earn FDA clearance for a digital therapeutic product, at $1.6 billion.



from Section Page News - Modern Healthcare https://ift.tt/3gVEXfx

No comments:

Post a Comment